Call Us: Email: novopept@gmail.com
enLanguage
Sugammadex Sodium CAS 343306-79-6

Sugammadex Sodium CAS 343306-79-6

What is Sugammadex Sodium ? Sugammadex Sodium (CAS 343306-79-6) is the sodium salt form of sugammadex , a chemically modified gamma-cyclodextrin with the molecular formula C₇₂H₁₀₄Na₈O₄₈S₈ and a molecular weight of approximately 2178 g/mol . It is a synthetic pharmaceutical compound classified as...

What is Sugammadex Sodium ?

 

Sugammadex Sodium (CAS 343306-79-6) is the sodium salt form of sugammadex, a chemically modified gamma-cyclodextrin with the molecular formula C₇₂H₁₀₄Na₈O₄₈S₈ and a molecular weight of approximately 2178 g/mol. It is a synthetic pharmaceutical compound classified as a selective relaxant binding agent (SRBA).

 

Parameter

Details

CAS Number

343306-79-6

Synonyms

ORG 25969, Sugammadex Octasodium Salt, Bridion (Brand Name)

Chemical Name

$\gamma$-Cyclodextrin, 6A,6B,6C,6D,6E,6F,6G,6H-octakis-$S$-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-, octasodium salt

Molecular Formula

C₇₂H₁₀₄Na₈O₄₈S₈

Molecular Weight

~2178 g/mol

Therapeutic Category

Anesthesia / Neuromuscular Blockade Reversal Agent

Formulation Route

Injectable (Intravenous Solution)

 

Mechanism of Action

 

The Breakthrough of SRBA Technology

1. Encapsulation Mechanism

Sugammadex is a modified γ-cyclodextrin, engineered into a hollow, truncated-cone structure.

The lipophilic inner cavity attracts hydrophobic steroid molecules.

The hydrophilic outer surface ensures high aqueous solubility.
This architecture enables Sugammadex to act as a molecular "host" capable of trapping its "guest" molecule.


2. Selective Target Binding

The lipophilic core of Sugammadex has a strong affinity for the steroid nucleus of aminosteroid non-depolarizing neuromuscular blocking drugs (NMBDs)-primarily Rocuronium and, to a lesser extent, Vecuronium.
This binding selectivity is what differentiates SRBA technology from all previous reversal methods.


3. Formation of a Stable Host–Guest Complex

Upon encountering rocuronium or vecuronium in the plasma, Sugammadex forms a tight, water-soluble, biologically inactive 1:1 complex.
This complex prevents the NMBD from interacting with nicotinic receptors at the neuromuscular junction.


4. Creation of a Concentration Gradient

By binding the NMBDs in the central circulation, Sugammadex quickly reduces the free plasma concentration of these agents.
This drop establishes a strong concentration gradient, pulling additional NMBD molecules away from the neuromuscular junction into the plasma-where they are rapidly encapsulated and neutralized.


5. Rapid and Complete Reversal

As the amount of unbound NMBD falls sharply, fewer molecules are available to block the nicotinic acetylcholine receptors. The result is:

  • Fast recovery of neuromuscular function
  • Predictable reversal, even from deep blockade
  • Minimal risk of residual paralysis

 

What is Sugammadex Sodium Used For?

 

Sugammadex Sodium is indicated for the reversal of neuromuscular blockade induced by Rocuronium bromide and Vecuronium bromide in adult patients and pediatric patients (typically 2 years and older) undergoing surgery.

Routine Reversal: Reversal of moderate or deep blockade.

Immediate Reversal: Unique ability to reverse deep or profound neuromuscular blockade quickly, providing a critical tool for anesthesiologists in high-risk or emergency situations.

Improved Patient Safety: By achieving a faster and more complete reversal, Sugammadex significantly reduces the incidence of Postoperative Residual Curarization (PORC), which is associated with serious complications like upper airway obstruction and respiratory failure.

 

 

common side effects

 

1. Hypersensitivity & Anaphylaxis

 

  • Mild reactions: rash, urticaria (hives), pruritus
  • Severe reactions: bronchospasm, hypotension, cardiovascular collapse. Although rare, anaphylaxis has been reported even at standard doses.

 


2. Cardiovascular Reactions

  • Bradycardia, occasionally profound
  • In rare cases, asystole has been reported

Continuous monitoring is recommended, especially immediately after administration.

 


3. Respiratory-Related Effects

  • Cough
  • Laryngospasm (rare)

These typically occur in the context of emergence from anesthesia.

 


4. Gastrointestinal Symptoms

  • Nausea
  • Vomiting

These are among the most commonly reported and typically self-limited.

 


5. Neuromuscular / Postoperative Effects

  • Recovery-related muscle weakness (rare, generally due to inadequate dosing or rapid re-paralysis)
  • Possible recurrence of blockade if an insufficient dose is administered

 

 

 

Hot Tags:

Sugammadex Sodium API,Sugammadex Sodium bulk supply, Sugammadex Sodium manufacturer, Sugammadex Sodium supplier China, Sugammadex Sodium factory price, Sugammadex Sodium GMP manufacturer, Sugammadex Sodium EP/USP grade, Sugammadex Sodium pharmaceutical intermediate, Sugammadex Sodium raw material, Sugammadex Sodium CAS 343306-79-6, Sugammadex Sodium bulk powder, Sugammadex Sodium high purity, Rocuronium reversal agent API

 

 

Message us to get your personalized quotation within 24 hours.

 

  • Whatsapp:+852 6736 4057

  • Telegram:@hinovopept

  • Email:novopept@gmail.com

novopept contact

 

Hot Tags: sugammadex sodium cas 343306-79-6, China sugammadex sodium cas 343306-79-6 manufacturers, suppliers, factory

Send Inquiry

(0/10)

clearall